CY1112014T1 - Συνθεσεις αντιβακτηριακων εμβολιων - Google Patents
Συνθεσεις αντιβακτηριακων εμβολιωνInfo
- Publication number
- CY1112014T1 CY1112014T1 CY20111100401T CY111100401T CY1112014T1 CY 1112014 T1 CY1112014 T1 CY 1112014T1 CY 20111100401 T CY20111100401 T CY 20111100401T CY 111100401 T CY111100401 T CY 111100401T CY 1112014 T1 CY1112014 T1 CY 1112014T1
- Authority
- CY
- Cyprus
- Prior art keywords
- vaccine compositions
- antibacterial vaccine
- gram
- negative bacterial
- virulence genes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/809,665 US6790950B2 (en) | 1999-04-09 | 2001-03-15 | Anti-bacterial vaccine compositions |
| EP02705915A EP1368456B1 (en) | 2001-03-15 | 2002-01-17 | Anti-bacterial vaccine compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1112014T1 true CY1112014T1 (el) | 2015-11-04 |
Family
ID=25201919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111100401T CY1112014T1 (el) | 2001-03-15 | 2011-04-18 | Συνθεσεις αντιβακτηριακων εμβολιων |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US6790950B2 (https=) |
| EP (1) | EP1368456B1 (https=) |
| JP (2) | JP2005502315A (https=) |
| AR (2) | AR035745A1 (https=) |
| AT (1) | ATE500316T1 (https=) |
| AU (1) | AU2002240033B2 (https=) |
| CA (2) | CA2438315C (https=) |
| CY (1) | CY1112014T1 (https=) |
| DE (1) | DE60239318D1 (https=) |
| DK (1) | DK1368456T3 (https=) |
| ES (1) | ES2362041T3 (https=) |
| MX (1) | MXPA03008296A (https=) |
| NZ (1) | NZ528208A (https=) |
| PE (1) | PE20021008A1 (https=) |
| PT (1) | PT1368456E (https=) |
| SI (1) | SI1368456T1 (https=) |
| TW (4) | TWI328035B (https=) |
| WO (1) | WO2002075507A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6455323B1 (en) * | 1997-07-03 | 2002-09-24 | Pharmacia & Upjohn Company | Anti-bacterial methods and materials |
| HK1045856A1 (zh) | 1999-04-09 | 2002-12-13 | 法玛西雅厄普约翰美国公司 | 抗细菌疫苗组合物 |
| US6790950B2 (en) * | 1999-04-09 | 2004-09-14 | Pharmacia & Upjohn Company | Anti-bacterial vaccine compositions |
| CA2881568C (en) | 2000-10-27 | 2019-09-24 | Novartis Vaccines And Diagnostics, Inc. | Nucleic acids and proteins from streptococcus groups a & b |
| US7449178B2 (en) * | 2002-04-05 | 2008-11-11 | Merial Limited | Attenuated gram negative bacteria |
| US7794734B2 (en) * | 2002-10-30 | 2010-09-14 | The Board Of Regents For Oklahoma State University | Mannheimia haemolytica chimeric outer membrane protein PlpE and leukotoxin epitopes as a vaccine or vaccine component against shipping fever |
| GB0228691D0 (en) * | 2002-12-09 | 2003-01-15 | Imp College Innovations Ltd | Bacterial virulence genes |
| ES2505695T3 (es) | 2003-07-31 | 2014-10-10 | Novartis Vaccines And Diagnostics, Inc. | Composiciones inmunógenas para Streptococcus pyogenes |
| US8945589B2 (en) | 2003-09-15 | 2015-02-03 | Novartis Vaccines And Diagnostics, Srl | Immunogenic compositions for Streptococcus agalactiae |
| US9107864B2 (en) * | 2004-06-07 | 2015-08-18 | Qu Biologics Inc. | Tissue targeted antigenic activation of the immune response to treat cancers |
| US8937154B2 (en) | 2006-10-05 | 2015-01-20 | New York Blood Center, Inc. | Stabilized therapeutic small helical antiviral peptides |
| EP2073829B1 (en) * | 2006-10-05 | 2012-06-20 | New York Blood Center, Inc. | Stabilized therapeutic small helical antiviral peptides |
| KR101621837B1 (ko) | 2007-09-12 | 2016-05-17 | 노파르티스 아게 | Ｇａｓ57 돌연변이 항원 및 ｇａｓ57 항체 |
| WO2009137532A1 (en) | 2008-05-06 | 2009-11-12 | New York Blood Center | Antiviral cell penetrating peptides |
| AU2009266920A1 (en) * | 2008-07-03 | 2010-01-07 | Biotechnology Research And Development Corporation | Vaccines comprising Pasteurella multocida recombinant filamentous hemagglutinin peptides |
| CA2774636C (en) | 2009-09-25 | 2019-05-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Neutralizing antibodies to hiv-1 and their use |
| US9163284B2 (en) | 2013-08-09 | 2015-10-20 | President And Fellows Of Harvard College | Methods for identifying a target site of a Cas9 nuclease |
| EP3062816B1 (en) * | 2013-11-01 | 2020-08-05 | Boehringer Ingelheim Animal Health USA Inc. | Attenuated pasteurella multocida vaccines & methods of making & use thereof |
| CN116593695B (zh) * | 2022-12-29 | 2025-08-05 | 重庆澳龙生物制品有限公司 | 一种牛多杀性巴氏杆菌荚膜a型elisa抗体检测试剂盒及其制备方法和应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4735801A (en) | 1982-09-07 | 1988-04-05 | Board Of Trustees Of Leland Stanford Jr. University | Novel non-reverting salmonella live vaccines |
| US5077044A (en) | 1980-05-19 | 1991-12-31 | The Board Of Trustees Of The Leland Stanford Jr. University | Novel non-reverting shigella live vaccines |
| SE8205892D0 (sv) | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
| SE8405493D0 (sv) | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
| US4877612A (en) | 1985-05-20 | 1989-10-31 | Frank M. Berger | Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process |
| ATE71303T1 (de) | 1986-01-14 | 1992-01-15 | Nederlanden Staat | Verfahren zur herstellung immunologischer komplexe und diese enthaltende pharmazeutische zusammensetzung. |
| US4806352A (en) | 1986-04-15 | 1989-02-21 | Ribi Immunochem Research Inc. | Immunological lipid emulsion adjuvant |
| CA1340522C (en) | 1987-03-10 | 1999-05-04 | Heinz Dobeli | Fusion proteins containing neighbouring histidines for improved purification |
| IL86583A0 (en) | 1987-06-04 | 1988-11-15 | Molecular Eng Ass | Vaccine containing a derivative of a microbe and method for the production thereof |
| JP3415145B2 (ja) | 1991-03-05 | 2003-06-09 | ザ ウエルカム ファウンデーション リミテッド | 弱毒化細菌における組換えタンパク質の発現 |
| US5840312A (en) | 1991-05-02 | 1998-11-24 | Institut Pasteur | Recombinant Bacillus anthracis strains unable to produce the lethal factor protein or edema factor protein |
| EP0668779A4 (en) | 1992-11-06 | 1996-08-21 | Univ Minnesota | Vaccine to protect against pasteurellosis - infection by P.multocida. |
| US5585277A (en) | 1993-06-21 | 1996-12-17 | Scriptgen Pharmaceuticals, Inc. | Screening method for identifying ligands for target proteins |
| DE19502584C2 (de) | 1994-01-28 | 1999-08-12 | Medigene Ag Ges Fuer Molekular | Verfahren zur Bestimmung der Aktivität eines regulatorischen Faktors sowie Verwendung dieses Verfahrens |
| KR100551104B1 (ko) | 1994-12-09 | 2006-02-09 | 임페리얼 컬리지 이노베이션스 리미티드 | 유전자의 동정 |
| GB9518220D0 (en) | 1995-09-06 | 1995-11-08 | Medical Res Council | Checkpoint gene |
| ATE419371T1 (de) * | 1996-09-06 | 2009-01-15 | Jensen Peter Ruhdal | Verfahren zur verbesserung der herstellung eines erwünschten produktes aus einer zelle |
| US6673538B1 (en) * | 1997-07-25 | 2004-01-06 | The Trustees Of Boston University | Methods and compositions for designing vaccines |
| HK1045856A1 (zh) | 1999-04-09 | 2002-12-13 | 法玛西雅厄普约翰美国公司 | 抗细菌疫苗组合物 |
| US6790950B2 (en) * | 1999-04-09 | 2004-09-14 | Pharmacia & Upjohn Company | Anti-bacterial vaccine compositions |
| AU4204800A (en) * | 1999-07-12 | 2001-01-30 | Xoma Technology Ltd. | Method to identify inhibitors f1/f0 atpase |
| US20030180330A1 (en) * | 2000-04-27 | 2003-09-25 | Meyer Thomas F | Method for identifying helicobacter antigens |
-
2001
- 2001-03-15 US US09/809,665 patent/US6790950B2/en not_active Expired - Lifetime
-
2002
- 2002-01-17 EP EP02705915A patent/EP1368456B1/en not_active Expired - Lifetime
- 2002-01-17 ES ES02705915T patent/ES2362041T3/es not_active Expired - Lifetime
- 2002-01-17 WO PCT/US2002/001971 patent/WO2002075507A2/en not_active Ceased
- 2002-01-17 AU AU2002240033A patent/AU2002240033B2/en not_active Expired
- 2002-01-17 CA CA2438315A patent/CA2438315C/en not_active Expired - Lifetime
- 2002-01-17 CA CA2852293A patent/CA2852293A1/en not_active Abandoned
- 2002-01-17 SI SI200230939T patent/SI1368456T1/sl unknown
- 2002-01-17 NZ NZ528208A patent/NZ528208A/en not_active IP Right Cessation
- 2002-01-17 AT AT02705915T patent/ATE500316T1/de active
- 2002-01-17 DE DE60239318T patent/DE60239318D1/de not_active Expired - Lifetime
- 2002-01-17 PT PT02705915T patent/PT1368456E/pt unknown
- 2002-01-17 MX MXPA03008296A patent/MXPA03008296A/es active IP Right Grant
- 2002-01-17 DK DK02705915.3T patent/DK1368456T3/da active
- 2002-01-17 JP JP2002574050A patent/JP2005502315A/ja active Pending
- 2002-02-07 AR ARP020100402A patent/AR035745A1/es not_active Application Discontinuation
- 2002-02-08 TW TW091102640A patent/TWI328035B/zh not_active IP Right Cessation
- 2002-02-08 TW TW099122912A patent/TWI335934B/zh not_active IP Right Cessation
- 2002-02-08 TW TW097148939A patent/TWI334884B/zh not_active IP Right Cessation
- 2002-02-08 TW TW099122913A patent/TWI335935B/zh not_active IP Right Cessation
- 2002-02-27 PE PE2002000160A patent/PE20021008A1/es not_active Application Discontinuation
-
2004
- 2004-05-26 US US10/854,299 patent/US7476391B2/en not_active Expired - Lifetime
-
2009
- 2009-05-22 AR ARP090101850A patent/AR071888A2/es unknown
-
2010
- 2010-11-04 JP JP2010247585A patent/JP2011097938A/ja active Pending
-
2011
- 2011-04-18 CY CY20111100401T patent/CY1112014T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20040110268A1 (en) | 2004-06-10 |
| SI1368456T1 (sl) | 2011-06-30 |
| PE20021008A1 (es) | 2002-11-13 |
| CA2852293A1 (en) | 2002-09-26 |
| JP2011097938A (ja) | 2011-05-19 |
| WO2002075507B1 (en) | 2003-12-11 |
| WO2002075507A2 (en) | 2002-09-26 |
| TWI335934B (en) | 2011-01-11 |
| NZ528208A (en) | 2008-04-30 |
| WO2002075507A3 (en) | 2003-09-12 |
| ATE500316T1 (de) | 2011-03-15 |
| TW201040261A (en) | 2010-11-16 |
| AR035745A1 (es) | 2004-07-07 |
| EP1368456B1 (en) | 2011-03-02 |
| US7476391B2 (en) | 2009-01-13 |
| TWI335935B (en) | 2011-01-11 |
| AR071888A2 (es) | 2010-07-21 |
| PT1368456E (pt) | 2011-06-01 |
| CA2438315A1 (en) | 2002-09-26 |
| US20050003512A1 (en) | 2005-01-06 |
| TW201040262A (en) | 2010-11-16 |
| EP1368456A2 (en) | 2003-12-10 |
| MXPA03008296A (es) | 2007-05-28 |
| DK1368456T3 (da) | 2011-05-23 |
| TWI328035B (en) | 2010-08-01 |
| ES2362041T3 (es) | 2011-06-27 |
| US6790950B2 (en) | 2004-09-14 |
| TW200916577A (en) | 2009-04-16 |
| AU2002240033B2 (en) | 2007-11-08 |
| DE60239318D1 (de) | 2011-04-14 |
| JP2005502315A (ja) | 2005-01-27 |
| TWI334884B (en) | 2010-12-21 |
| CA2438315C (en) | 2014-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1112014T1 (el) | Συνθεσεις αντιβακτηριακων εμβολιων | |
| CY1110914T1 (el) | Δικυκλο-πυραζολες δραστικες ως αναστολεις kinασων, διεργασια για την παρασκευη τους και φαρμακευτικες συνθεσεις που τις περιλαμβανουν | |
| ATE485056T1 (de) | Verbesserte impfstoffe | |
| MY125202A (en) | Vaccine | |
| CY1118480T1 (el) | Παραγωγα toy uk-2a | |
| CY1105194T1 (el) | Φωσφονικα παραγωγα γλυκοπεπτιδιων | |
| DK1187629T3 (da) | Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid | |
| CY1114243T1 (el) | Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων | |
| DK1103564T3 (da) | Cancerantigener baseret på tumorsuppressorgen WT1-produkt | |
| CY1105221T1 (el) | Ιατρικη χρηση θυρεοειδομιμητικων ενωσεων για την θepαπευτικη αγωγη της τριχοπτωσης και φαρμακευτικες συνθεσεις | |
| CY1107950T1 (el) | Νεϊσσεριακες συνθεσεις εμβολιου και μεθοδοι | |
| CY1112871T1 (el) | Μεθοδος κι ενδιαμεσες ενωσεις | |
| NO992102L (no) | Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen | |
| WO2000061724A3 (en) | Anti-bacterial vaccine compositions | |
| ATE375391T1 (de) | Chlamydia-antigene und entsprechende dna- fragmente und deren verwendungen | |
| ATE355104T1 (de) | Haarbehandlungsmittel | |
| SG167667A1 (en) | Nucleic acid compositions for stimulating immune responses | |
| CY1106133T1 (el) | Αγωνιστες υποδοχεα 2 παραγοντα απελευθερωσης κορτικοτροπινης | |
| WO1999001473A3 (en) | Anti-bacterial methods and materials | |
| DE60011560D1 (de) | Salmonella Impfstoff, der keinen Antikörper gegen Flagellin oder gegen Flagella induziert | |
| CY1107560T1 (el) | Ζωντανα εξασθενημενα βακτηρια για χρηση σε εμβολιο | |
| NO20013102D0 (no) | Gener, proteiner og deres anvendelse | |
| PL372769A1 (en) | Cyanoguanidine prodrugs | |
| DE60226057D1 (de) | Geflügelkrankheit verursachendes bakterium und daraus stammender impfstoff | |
| ATE353226T1 (de) | Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form |